The invention discloses a
target drug for treating
thyroid cancer and applications thereof. Through long term research, for the first time, the inventor finds that aluminum
sulfate can recognize the normal tissues and
cancer tissues of
human body, can change the physiological features of
cancer cells, can inhibit cancer cells from secreting multiple
proteases, and inhibits the
metabolism of mitochondria of cancer cells. The
drug can treat cancers. The
drug can be combined with the
DNA of cancer cells to promote the
DNA cleavage,
glycoprotein on the
cell surface can be rapidly astringed and agglomerated, the structure of proteins on the
cell surface is effectively changed, the
signal channel is obstructed, the
cell microstructure is changed, the
drug combines with succinodehydrogenase in cell mitochondria, the proliferation and migration of cancer cells are controlled effectively, and the
cancer cell inhibition rate is as high as 99.8 to 99.9% or even 100%. The
side effect of aluminum
sulfate is small, the safety is high, the
oral administration has the advantages of low dosage, rapid effect, and short treatment course; the
tumor size can be reduced rapidly, the
apoptosis is induced, the proliferation is inhibited, finally the cancer cells fall off in fragments, and the drug has an important meaning for
thyroid cancer treatment.